These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29684335)

  • 21. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocannabinoid system in neurodegenerative disorders.
    Basavarajappa BS; Shivakumar M; Joshi V; Subbanna S
    J Neurochem; 2017 Sep; 142(5):624-648. PubMed ID: 28608560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNAs in neurodegenerative diseases.
    Yang S; Yang H; Luo Y; Deng X; Zhou Y; Hu B
    Neurochem Int; 2021 Sep; 148():105096. PubMed ID: 34118305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers of neurodegenerative disorders: how good are they?
    Rachakonda V; Pan TH; LE WD
    Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wearable GPS and Accelerometer Technologies for Monitoring Mobility and Physical Activity in Neurodegenerative Disorders: A Systematic Review.
    Breasail MÓ; Biswas B; Smith MD; Mazhar MKA; Tenison E; Cullen A; Lithander FE; Roudaut A; Henderson EJ
    Sensors (Basel); 2021 Dec; 21(24):. PubMed ID: 34960353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circuit Mechanisms of Neurodegenerative Diseases: A New Frontier With Miniature Fluorescence Microscopy.
    Werner CT; Williams CJ; Fermelia MR; Lin DT; Li Y
    Front Neurosci; 2019; 13():1174. PubMed ID: 31736701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphometric and Nanomechanical Screening of Peripheral Blood Cells with Atomic Force Microscopy for Label-Free Assessment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
    Taneva SG; Todinova S; Andreeva T
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unbiased approaches to biomarker discovery in neurodegenerative diseases.
    Chen-Plotkin AS
    Neuron; 2014 Nov; 84(3):594-607. PubMed ID: 25442938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.
    Bach JP; Gold M; Mengel D; Hattesohl A; Lubbe D; Schmid S; Tackenberg B; Rieke J; Maddula S; Baumbach JI; Nell C; Boeselt T; Michelis J; Alferink J; Heneka M; Oertel W; Jessen F; Janciauskiene S; Vogelmeier C; Dodel R; Koczulla AR
    PLoS One; 2015; 10(7):e0132227. PubMed ID: 26168044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Ontario Neurodegenerative Disease Research Initiative (ONDRI).
    Farhan SM; Bartha R; Black SE; Corbett D; Finger E; Freedman M; Greenberg B; Grimes DA; Hegele RA; Hudson C; Kleinstiver PW; Lang AE; Masellis M; McIlroy WE; McLaughlin PM; Montero-Odasso M; Munoz DG; Munoz DP; Strother S; Swartz RH; Symons S; Tartaglia MC; Zinman L; ; Strong MJ
    Can J Neurol Sci; 2017 Mar; 44(2):196-202. PubMed ID: 28003035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CSF biomarkers in neurodegenerative and vascular dementias.
    Llorens F; Schmitz M; Ferrer I; Zerr I
    Prog Neurobiol; 2016; 138-140():36-53. PubMed ID: 27016008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomics Approach to Identify Biomarkers in Neurodegenerative Diseases.
    Nayak A; Salt G; Verma SK; Kishore U
    Int Rev Neurobiol; 2015; 121():59-86. PubMed ID: 26315762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular vesicles in neurodegenerative diseases.
    Croese T; Furlan R
    Mol Aspects Med; 2018 Apr; 60():52-61. PubMed ID: 29137922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Young-onset dementia.
    Kuruppu DK; Matthews BR
    Semin Neurol; 2013 Sep; 33(4):365-85. PubMed ID: 24234358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiparametric magnetic resonance imaging and positron emission tomography findings in neurodegenerative diseases: Current status and future directions.
    Soni N; Ora M; Bathla G; Nagaraj C; Boles Ponto LL; Graham MM; Saini J; Menda Y
    Neuroradiol J; 2021 Aug; 34(4):263-288. PubMed ID: 33666110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of functional imaging in Parkinsonism and dementia.
    Burn DJ; O'Brien JT
    Mov Disord; 2003 Sep; 18 Suppl 6():S88-95. PubMed ID: 14502661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary Redox Biomarkers in Selected Neurodegenerative Diseases.
    Maciejczyk M; Zalewska A; Gerreth AK
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32059422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroimaging diagnosis in neurodegenerative diseases.
    Szymański P; Markowicz M; Janik A; Ciesielski M; Mikiciuk-Olasik E
    Nucl Med Rev Cent East Eur; 2010; 13(1):23-31. PubMed ID: 21154313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.
    Atri A
    Handb Clin Neurol; 2016; 136():971-84. PubMed ID: 27430453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ambulatory Activity Components Deteriorate Differently across Neurodegenerative Diseases: A Cross-Sectional Sensor-Based Study.
    Klenk J; Srulijes K; Schatton C; Schwickert L; Maetzler W; Becker C; Synofzik M
    Neurodegener Dis; 2016; 16(5-6):317-23. PubMed ID: 27197840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.